Insilico Medicine

Verified

AI-powered drug discovery platform — from target identification to clinical trials.

4.3

EnterpriseAI Science & Healthcare

Pricing

Enterprise

About Insilico Medicine

Insilico Medicine uses AI across the entire drug discovery pipeline: identifying disease targets, generating novel molecules, and predicting clinical trial outcomes. Their platform has already advanced AI-discovered drugs to human clinical trials.

Key Features

End-to-end AI drug discovery
Target identification with PandaOmics
Molecule generation with Chemistry42
Clinical trial outcome prediction
Multiple drugs in clinical trials

Pros & Cons

Pros

+ Full pipeline AI drug discovery

+ Real drugs in clinical trials

+ Strong publication record

Cons

- Enterprise-only pricing

- Not accessible to individual researchers

- Drug discovery timelines are still long

Use Cases

Drug target identificationNovel molecule designClinical trial optimizationPharmaceutical R&D acceleration